Biotechnology Stocks
| # | Ultimi 7 Giorni | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 4823 |  BGMS Bio Green Med Solution, Inc. - Common Stock | 0.82 USD | -3.53% | -6.82% | -5.75% | -84.62% | 5.43 M USD | ||
| 4833 |  CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 USD | +14.74% | +9.67% | +17.11% | +68.94% | 5.08 M USD | ||
| 4837 |  XBIO Xenetic Biosciences, Inc. - Common Stock | 2.12 USD | -4.07% | -7.83% | -48.92% | -75.60% | 4.97 M USD | ||
| 4838 |  LIMN Liminatus Pharma, Inc. - Class A Common Stock | 3.69 USD | -4.65% | -1.60% | +4.24% | +138.06% | 4.96 M USD | ||
| 4845 |  NCNA NuCana plc - American Depositary Shares | 1.13 USD | -0.88% | -5.83% | -16.91% | -47.44% | 4.70 M USD | ||
| 4848 |  XTLB XTL Biopharmaceuticals Ltd - American Depositary Shares | 1.98 USD | 0.00% | -8.76% | -20.16% | +120.00% | 4.68 M USD | ||
| 4857 |  ENLV Enlivex Ltd. - Ordinary Shares | 0.28 USD | -9.68% | -33.33% | -73.08% | -76.07% | 4.43 M USD | ||
| 4863 |  DRMA Dermata Therapeutics, Inc. - Common Stock | 1.07 USD | -4.46% | -7.76% | -11.57% | -25.17% | 4.30 M USD | ||
| 4864 |  PMCB PharmaCyte Biotech, Inc. - Common Stock | 0.40 USD | -2.44% | -2.44% | -16.67% | -60.00% | 4.29 M USD | ||
| 4873 |  ERNA Ernexa Therapeutics Inc. - Common Stock | 2.49 USD | +4.18% | -17.00% | -36.64% | +611.43% | 4.06 M USD | ||
| 4878 |  ADXN Addex Therapeutics Ltd - American Depositary Shares | 3.18 USD | +6.71% | +4.26% | -13.35% | -63.78% | 3.92 M USD | ||
| 4886 |  PCSA Processa Pharmaceuticals, Inc. - Common Stock | 1.35 USD | -4.93% | -21.97% | -32.16% | -39.19% | 3.77 M USD | ||
| 4891 |  GRI GRI Bio, Inc. - Common Stock | 1.68 USD | -9.19% | -16.00% | -6.15% | -36.60% | 3.67 M USD | ||
| 4897 |  EVGN Evogene Ltd. - Ordinary Shares | 0.40 USD | -2.44% | -2.44% | -20.00% | -69.92% | 3.49 M USD | ||
| 4899 |  SXTP 60 Degrees Pharmaceuticals, Inc. - Common Stock | 0.97 USD | -11.82% | -24.22% | +3.19% | -40.85% | 3.41 M USD | ||
| 4901 |  CVKD Cadrenal Therapeutics, Inc. - Common Stock | 0.93 USD | -4.12% | -5.10% | -20.51% | -83.15% | 3.32 M USD | ||
| 4905 |  APVO Aptevo Therapeutics Inc. - Common Stock | 1.80 USD | -2.17% | 0.00% | -2.70% | -73.33% | 3.24 M USD | ||
| 4909 |  REVB Revelation Biosciences, Inc. - Common Stock | 0.78 USD | -6.02% | -3.70% | -22.00% | -43.48% | 3.11 M USD | ||
| 4912 |  MLEC Moolec Science SA - Ordinary Shares | 4.19 USD | -12.89% | -13.61% | -38.38% | +398.81% | 3.04 M USD | ||
| 4918 |  MBIO Mustang Bio, Inc. - Common Stock | 0.41 USD | -8.89% | -12.77% | -24.07% | -52.87% | 2.97 M USD |
Notizie Biotechnology Stocks
Il farmaco di Pharvaris per l’HAE mostra un sollievo più rapido
Raymond James avvia la copertura di Kymera Therapeutics con rating outperform
Raymond James avvia la copertura di Nektar con rating Market Perform
Palisade Bio: Raymond James avvia copertura con rating Outperform
Raymond James conferma il rating su Liquidia tra i ricorsi legali
Tenax Therapeutics sospende temporaneamente l’arruolamento nello studio LEVEL-2 di TNX-103 per modificare i criteri; richiede un incontro con la FDA
Ginkgo Bioworks supporterà NSF X-Labs con accesso al laboratorio
Gainers Biotechnology Stocks
 GRDX GridAI Technologies Corp. - Common Stock | 4.80 | +16.50% |
CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
 IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
 ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
 CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
 SRZN Surrozen, Inc. - Common Stock | 27.97 | +11.26% |
 ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 | +10.39% |
 QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
 YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
 CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
 TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
 KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
 BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |
 LPCN Lipocine Inc. - Common Stock | 1.93 | -12.27% |